Guha, P. Et Al. 2011. Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, and T-cell apoptosis. NIH & FDA Glycosciences Research Day , (Bathesda, United States Of America), 23.

Guha, P., KAPTAN, E., Bandyopadhyaya, G., Kalvakolanu, D., Vasta, G. R., & Ahmed, H., (2011). Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, and T-cell apoptosis . NIH & FDA Glycosciences Research Day (pp.23). Bathesda, United States Of America

Guha, Prasun Et Al. "Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, and T-cell apoptosis," NIH & FDA Glycosciences Research Day, Bathesda, United States Of America, 2011

Guha, Prasun Et Al. "Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, and T-cell apoptosis." NIH & FDA Glycosciences Research Day , Bathesda, United States Of America, pp.23, 2011

Guha, P. Et Al. (2011) . "Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, and T-cell apoptosis." NIH & FDA Glycosciences Research Day , Bathesda, United States Of America, p.23.

@conferencepaper{conferencepaper, author={Prasun Guha Et Al. }, title={Natural Thomsen-Friedenreich disaccharide (TFD) containing compound prevents galectin-3-mediated tumor-endothelial cell adhesion, angiogenesis, and T-cell apoptosis}, congress name={NIH & FDA Glycosciences Research Day}, city={Bathesda}, country={United States Of America}, year={2011}, pages={23} }